严重COVID-19中血管性血友病因子前肽升高:急性且持续内皮细胞活化的证据
本研究探讨严重COVID-19中内皮细胞活化的性质,检测血浆VWF抗原、VWF前肽及凝血因子VIII水平。结果显示VWF:Ag、FVIII和VWFpp均显著升高,VWFpp/VWF:Ag比值降低,且VWFpp与SOFA评分、SIC评分及P/F比值相关,提示持续严重内皮活化,VWFpp可能作为生物标志物。
要点
- 严重COVID-19患者血浆VWF:Ag、FVIII和VWFpp水平显著升高。
- VWFpp/VWF:Ag比值降低,提示VWF清除减少参与VWF:Ag升高。
- VWFpp与SOFA评分、SIC评分及P/F比值相关,可能作为生物标志物。
核心结论
- 严重COVID-19存在急性且持续的内皮细胞活化,VWFpp可能作为该状态的生物标志物。
研究设计与样本
- 本研究对严重SARS-CoV-2感染患者进行血浆VWF:Ag、FVIII和VWFpp检测及连续监测。
主要发现
- 连续检测显示VWF-FVIII复合物水平升高持续长达3周。
- VWFpp/VWF:Ag比值降低,提示VWF清除减少。
关键数值与推荐
- VWFpp水平与SOFA评分、SIC评分及P/F比值相关。
临床怎么用
- VWFpp可能用于评估严重COVID-19的内皮细胞活化状态和疾病严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endothelial cell (EC) activation plays a key role in the pathogenesis of pulmonary microvascular occlusion, which is a hallmark of severe coronavirus disease 2019 (COVID-19). Consistent with EC activation, increased plasma von Willebrand factor antigen (VWF:Ag) levels have been reported in COVID-19. Importantly however, studies in other microangiopathies have shown that plasma VWF propeptide (VWFpp) is a more sensitive and specific measure of acute EC activation. In the present study, we further investigated the nature of EC activation in severe COVID-19. Markedly increased plasma VWF:Ag [median (interquatile range, IQR) 608·8 (531-830)iu/dl] and pro-coagulant factor VIII (FVIII) levels [median (IQR) 261·9 (170-315) iu/dl] were seen in patients with severe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Sequential testing showed that these elevated VWF-FVIII complex levels remained high for up to 3 weeks. Similarly, plasma VWFpp levels were also markedly elevated [median (IQR) 324·6 (267-524) iu/dl]. Interestingly however, the VWFpp/VWF:Ag ratio was reduced, demonstrating that decreased VWF clearance contributes to the elevated plasma VWF:Ag levels in severe COVID-19. Importantly, plasma VWFpp levels also correlated with clinical severity indices including the Sequential Organ Failure Assessment (SOFA) score, Sepsis-Induced Coagulopathy (SIC) score and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (P/F ratio). Collectively, these findings support the hypothesis that sustained fulminant EC activation is occurring in severe COVID-19, and further suggest that VWFpp may have a role as a biomarker in this setting.
引用
- Ward SE, Curley GF, Lavin M, et al. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2020. PMID: 33326604. doi:10.1111/bjh.17273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。